Increased incidence of new-onset type-2 diabetes after cancer

It’s well-known that metabolic dysfunction, as seen in diabetes, is associated with a higher risk of cancer. But does the same applies the other way around? A newly published Danish cohort suggests so. Get elaboration in this MEDtalk with Associate Professor Lykke Sylow on how cancer induces metabolic dysfunction and new-onset type-2 diabetes.